Ampio Pharmaceuticals, Inc. (AMPE) Sees Significant Growth in Short Interest
Ampio Pharmaceuticals, Inc. (NYSE:AMPE) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 5,074,976 shares, a growth of 19.0% from the October 13th total of 4,264,623 shares. Approximately 7.4% of the company’s shares are short sold. Based on an average daily trading volume, of 1,355,536 shares, the short-interest ratio is presently 3.7 days.
Ampio Pharmaceuticals (NYSE:AMPE) opened at $1.24 on Tuesday. Ampio Pharmaceuticals has a 12-month low of $0.38 and a 12-month high of $1.34.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.
Receive News & Ratings for Ampio Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.